Dialectical behavioral therapy for Type 2 Diabetes
This trial is testing a new therapy to help improve quality of life and weight management in youth at risk for type 2 diabetes.
- Type 2 Diabetes
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment currently available for this trial?
"The clinical trial, which was first proposed on January 1st 2023 and last amended October 5th 2022, is actively seeking participants."
Who qualifies to participate in this clinical experiment?
"This study seeks 15 volunteers between 14 and 17 years old who present with prevention, a BMI z-score greater than 1.6, willingness to commit to the trial's procedures as well as evidence of mild-moderate depression (PHQ-9 score 5-19)."
How many individuals are currently enrolled in this research endeavor?
"That is accurate. According to the information on clinicaltrials.gov, this research project has been accepting recruits since 1/1/2023 and was most recently updated on 10/5/2022. The trial seeks 15 individuals from a single location."
Is the minimum age threshold for enrolment into this clinical research 18 years or older?
"The enrollment criteria for this research project allows individuals aged between 14 and 17 to participate. To further contextualize, there are 195 clinical trials available to minors while 1077 have been designed with elderly people in mind."
What objectives is this clinical trial aiming to accomplish?
"This research study has two primary outcomes that will be assessed over a duration of 32 weeks. These are enrollment rates and patient-centeredness, which is evaluated using focus groups and feedback forms. Secondary objectives include evaluating delivery of the behavioural intervention, barriers for lifestyle change (gathered through photovoice participation at 16 weeks), as well as other mental health co-morbidities related to self-regulation."